Jane Street
CRDF icon

Jane Street’s Cardiff Oncology CRDF Stock Holding History

Jane Street’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22,300
Closed -$45.9K – 11292
2025
Q3 		$45.9K Buy
+22,300
New +$61.6K ﹤0.01% 10374
2025
Q1 		– Sell
-49,900
Closed -$217K – 9575
2024
Q4 		$217K Buy
+49,900
New +$156K ﹤0.01% 8290
2024
Q3 		– Sell
-10,700
Closed -$23.8K – 9659
2024
Q2 		$23.8K Sell
10,700
-17,100
-62% -$64.4K ﹤0.01% 9027
2024
Q1 		$148K Buy
+27,800
New +$73.9K ﹤0.01% 8351
2022
Q2 		– Sell
-12,100
Closed -$30K – 9774
2022
Q1 		$30K Sell
12,100
-13,700
-53% -$48.5K ﹤0.01% 9826
2021
Q4 		$155K Sell
25,800
-58,000
-69% -$346K ﹤0.01% 8980
2021
Q3 		$558K Buy
83,800
+18,400
+28% +$116K ﹤0.01% 7080
2021
Q2 		$435K Sell
65,400
-14,200
-18% -$120K ﹤0.01% 7499
2021
Q1 		$737K Sell
79,600
-400
-0.5% -$4.86K ﹤0.01% 6063
2020
Q4 		$1.44M Buy
80,000
+4,300
+6% +$75.6K ﹤0.01% 4068
2020
Q3 		$1.07M Buy
+75,700
New +$500K ﹤0.01% 3983

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Jane Street's CRDF Position: Q1 2026 in Review

Jane Street reduced its Cardiff Oncology (CRDF) stake by 70% in Q1 2026, selling an estimated $190K and leaving 40,105 shares worth $65K. The position accounts for ﹤0.01% of the portfolio, ranked #10869.

Jane Street first reported a position in CRDF in Q4 2016 and has held it in 14 quarters since. The position peaked at $386K in Q1 2024. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Jane Street held 40,105 shares of Cardiff Oncology worth $65K as of Q1 2026.
  • Jane Street sold 92,745 Cardiff Oncology shares in Q1 2026, an estimated $190K.
  • Cardiff Oncology made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10869 holding.
  • Jane Street first reported a position in Cardiff Oncology in Q4 2016 and has held it in 14 quarters since.
  • Jane Street's Cardiff Oncology position peaked at $386K in Q1 2024.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.